advisory committee on immunization practices, Clinical Trials, glaxosmithkline, health medical pharma, influenza vaccine, moderna, palivizumab, Pfizer, pfizerbiontech covid 19 vaccine, respiratory syncytial virus, rochelle walensky, rsv vaccine, Tech Industry, Tech News, vaccine, vaccines
RSV Vaccines for Older Adults Should Be Here by the Fall
Vaccines for a common but sometimes dangerous virus are well on the way to reaching the public. This month, outside experts assembled by the Centers for Disease Control and Prevention gave their blessing to two vaccines developed against the respirator…
